Utility of Adipokines and IL-10 in Association with Anthropometry in Prediction of Insulin Resistance in Obese Children

References

• Gregory JW. Prevention of obesity and metabolic syndrome in children. Front Endocrinol. 2019;10:669. doi:10.3389/fendo.2019.00669
   PubMed Web of Science ®Google Scholar
• Taylor EB. The complex role of adipokines in obesity, inflammation, and autoimmunity. Clin Sci. 2021;135:731–752. doi:10.1042/CS20200895
   PubMed Web of Science ®Google Scholar
• Lo JC, Ljubicic S, Leibiger B, et al. Adipsin is an adipokine that improves beta cell function in diabetes. Cell. 2014;158:41–53. doi:10.1016/j.cell.2014.06.005
   PubMed Web of Science ®Google Scholar
• Zhang J, Li K, Pan L, et al. Association of circulating adipsin with nonalcoholic fatty liver disease in obese adults: a cross-sectional study. BMC Gastroenterol. 2021;21:131. doi:10.1186/s12876-021-01721-9
   Web of Science ®Google Scholar
• Nicholson T, Church C, Baker DJ, Jones SW. The role of adipokines in skeletal muscle inflammation and insulin sensitivity. J Inflamm. 2018;15:9. doi:10.1186/s12950-018-0185-8
   Google Scholar
• Acosta JR, Tavira B, Douagi I, et al. Human-specific function of IL-10 in adipose tissue linked to insulin resistance. J Clin Endocrinol Met. 2019;104(10):4552–4562. doi:10.1210/jc.2019-00341
   Web of Science ®Google Scholar
• Abdelhamid ER, Kamhawy AH, Ahmed HH, et al. Role of inflammatory cytokines in obese and nonobese diabetic children. Open Access Maced J Med Sci. 2020;8(B):858–865. doi:10.3889/oamjms.2020.4982
   Google Scholar
• Hung J, McQuillan BM, Thompson PL, Beilby JP. Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity. Int J Obes. 2008;32(5):772–779. doi:10.1038/sj.ijo.0803793
   Web of Science ®Google Scholar
• CDC. About child & teen BMI; division of nutrition, physical activity, and obesity; 2021. Available from: https://www.cdc.gov/healthyweight/assessing/BMI/childrens_BMI/about_childrens_BMI.html. Accessed October 17, 2022.
   Google Scholar
• Flynn JT, Kaelber DC, Baker-Smith CM, et al. Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics. 2017;140(3):e20171904. doi:10.1542/peds.2017-1904
   PubMed Web of Science ®Google Scholar
• Uniyal A, Narang M. Dyslipidemia in children. Indian J Medical Spe. 2021;12(3):116–121. doi:10.4103/injms.injms_17_21
   Web of Science ®Google Scholar
• Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–419. doi:10.1007/BF00280883
   PubMed Web of Science ®Google Scholar
• Irenewati S, Arkhaesi N, Wistiani W. Association of BMI measurements to waist circumference and waist-to-height ratio in overweight and obese children. Paediatr Indones. 2020;60(3):131–136. doi:10.14238/pi60
   Web of Science ®Google Scholar
• Soliman H, Ahmed S, Ibrahim A. Waist-to-height ratio as a clinical predictor for cardiovascular risks and insulin resistance in children and adolescents with exogenous obesity. Egypt Paediatr Assoc Gaz. 2021;69(1):1–6. doi:10.1186/s43054-021-00085-9
   Web of Science ®Google Scholar
• Rosaneli CF, Baena CP, Auler F, et al. Elevated blood pressure and obesity in childhood: a cross-sectional evaluation of 4609 Schoolchildren. Arq Bras Cardiol. 2014;103(3):238–244. doi:10.5935/abc.20140104
   Web of Science ®Google Scholar
• Reuter CP, da Silva PT, Renner JDP, et al. Dyslipidemia is associated with unfit and overweight-obese children and adolescents. Arq Bras Cardio. 2016;106(3):188–193. doi:10.5935/abc.20160025
   Web of Science ®Google Scholar
• Wang PG, Gong J, Wang SQ, Talbott EO, Zhang B, He QQ. Relationship of body fat and cardiorespiratory fitness with cardiovascular risk in Chinese children. PLoS One. 2011;6(11):e27896. doi:10.1371/journal.pone.0027896
   Web of Science ®Google Scholar
• Medeiros NI, Mattos RT, Menezes CA, et al. IL-10 and TGF-beta unbalanced levels in neutrophils contribute to increase inflammatory cytokine expression in childhood obesity. Eur J Nutr. 2018;57(7):2421–2430. doi:10.1007/s00394-017-1515-y
   PubMed Web of Science ®Google Scholar
• Chang J, Chang C, Chien EY, et al. Association between interleukin 1β and interleukin 10 concentrations: a cross-sectional study in young adolescents in Taiwan. BMC Pediatr. 2013;13:123. doi:10.1186/1471-2431-13-123
   Web of Science ®Google Scholar
• Lauridsen JK, Olesen RH, Vendelbo J, et al. High BMI levels associate with reduced mRNA expression of IL10 and increased mRNA expression of iNOS (NOS2) in human frontal cortex. Transl Psychiatry. 2017;7(2):e1044. doi:10.1038/tp.2016.259
   Web of Science ®Google Scholar
• Yao C, Du W, Chen H, Xiao S, Wang C-H, Fan Z-L. Associations of IL-10 gene polymorphisms with acute myeloid leukemia in Hunan, China. Asian Pac J Cancer Prev. 2013;14(4):2439–2442. doi:10.7314/APJCP
   Google Scholar
• Kupèa S, Jurka A, Marksa I, Rinkuþa I, Sipols AJ, Rumba-Rozenfelde I. Inflammatory cytokine IFN, IL-6, and IL-10 association with childhood obesity. Proc Latv Acad Sci. 2021;5(734):387–391. doi:10.2478/prolas-2021-0056
   Google Scholar
• Liu Y, Xu D, Yin C, Wang S, Wang M, Xiao Y. IL-10/STAT3 is reduced in childhood obesity with hypertriglyceridemia and is related to triglyceride level in diet-induced obese rats. BMC Endocr Disord. 2018;18:39. doi:10.1186/s12902-018-0265-z-
   Web of Science ®Google Scholar
• Calcaterra V, De Amici M, Klersy C, et al. Adiponectin, IL-10 and metabolic syndrome in obese children and adolescents. ACTA BIOMED. 2009;80:117–123.
   PubMedGoogle Scholar
• Moraitis AG, Freeman LA, Shamburek RD, et al. Elevated interleukin-10: a new cause of dyslipidemia leading to severe HDL deficiency. J Clin Lipidol. 2015;9(1):81–90. doi:10.1016/j.jacl.2014.09.014
   PubMed Web of Science ®Google Scholar
• Schroll A, Eller K, Feistritzer C, et al. Lipocalin 2 ameliorates granulocyte functionality. Eur J Immunol. 2012;42(12):3346–3357. doi:10.1002/eji.201142351
   PubMed Web of Science ®Google Scholar
• Zaki ME, El-Bassyouni H, Youness E, Mohamed N. Lipocalin-2 is an inflammatory biomarker associated with metabolic abnormalities in Egyptian obese children. J Appl Pharm Sci. 2015;5(05):007–012. doi:10.7324/JAPS.2015.50502
   Google Scholar
• Kanaka-Gantenbein C, Margeli A, Pervanidou P, et al. Retinol-binding protein 4 and lipocalin-2 in childhood and adolescent obesity: when children are not just “small adults. Clin Chem. 2008;54:1176–1182. doi:10.1373/clinchem.2007.099002
   PubMed Web of Science ®Google Scholar
• Wang Y, Lam KS, Kraegen EW, et al. Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humans. Clin Chem. 2007;53:34–41. doi:10.1373/clinchem.2006.075614
   PubMed Web of Science ®Google Scholar
• Gonzalez‑Gil AM, Peschard‑Franco M, Castillo EC, et al. Myokine–adipokine cross‑talk: potential mechanisms for the association between plasma irisin and adipokines and cardiometabolic risk factors in Mexican children with obesity and the metabolic syndrome. Diabetol Metab Syndr. 2019;11:63. doi:10.1186/s13098-019-0458-2
   PubMed Web of Science ®Google Scholar
• Vasilenkoa MA, Kirienkovaa EV, Skuratovskaiaa DA, Zatolokina PA, Mironyukb NI, Litvinova LS. The role of production of adipsin and leptin in the development of insulin resistance in patients with abdominal obesity. Prog Biophys Mol Bio. 2017;475:271–276. doi:10.1134/S160767291704010X
   Web of Science ®Google Scholar
• Czech MP. Insulin action and resistance in obesity and type 2 diabetes. Nat Med. 2017;23:804–814. doi:10.1038/nm.4350
   PubMed Web of Science ®Google Scholar
• Lim SM, Choi DP, Rhee Y, Kim HC. Association between obesity indices and insulin resistance among healthy Korean adolescents: the JS High School Study. PLoS One. 2015. doi:10.1371/journal.pone.0125238
   Web of Science ®Google Scholar
• Romualdoa MC, Nóbregab FJ, Escrivão MAMS. Insulin resistance in obese children and adolescents. J Pediatr. 2014;90(6):600–607. doi:10.1016/j.jped.2014.03.005
   Google Scholar
• Zhang Y, Foncea R, Deis JA, Guo H, Bernlohr DA, Chen X. Lipocalin 2 expression and secretion is highly regulated by metabolic stress, cytokines, and nutrients in adipocytes. PLoS One. 2014;9(5):e96997. doi:10.1371/journal.pone.0096997
   PubMed Web of Science ®Google Scholar
• Liu X, Hamnvik OP, Petrou M, et al. Circulating lipocalin 2 is associated with body fat distribution at baseline but is not an independent predictor of insulin resistance: the prospective Cyprus Metabolism Study. Eur J Endocrinol. 2011;165:805–812. doi:10.1530/EJE-11-0660
   Web of Science ®Google Scholar
• Han JM, Patterson SJ, Speck M, Ehses JA, Levings MK. Insulin inhibits IL-10–mediated regulatory T cell function: implications for obesity. J Immunology. 2014;192(2):623–629. doi:10.4049/jimmunol.1302181
   PubMed Web of Science ®Google Scholar
• Charles BA, Doumatey A, Huang H, et al. The roles of IL-6, IL-10, and IL-1RA in obesity and insulin resistance in African-Americans. J Clin Endocrinol Metab. 2011;96(12):E2018–E2022. doi:10.1210/jc.2011-1497
   PubMed Web of Science ®Google Scholar